Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
Abstract Serum neurofilament light chain (NfL) is emerging as an important biomarker in multiple sclerosis (MS). Our objective was to evaluate the prognostic value of serum NfL levels obtained close to the time of MS onset with long-term clinical outcomes. In this prospective cohort study, we identi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-67504-6 |